Viracta Therapeutics Inc【VIRX】株式ニュース

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Form 8-K - Current report

Viracta Therapeutics Announces Wind Down of Operations

SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage...

Form 8-K - Current report

Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives

SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

- Reprioritized resources to reduce costs and enhance focus on Nana-val’s development program in relapsed or...

Form 8-K - Current report

Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma

SAN DIEGO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage...

Renee 11月前

VIRX CUSIP suspended. FINRA deleted symbol.

https://otce.finra.org/otce/dailyList?viewType=Deletions

👍️0

Renee 1年前

Yoiks....that was an important zeeeeero. Glad you caught it,

👍️0

trader59 1年前

Left out a zero...
$.0678

👍️0

Renee 1年前

VIRX: Delisted from the Nasdaq to the OTC. ***pps dropped 55% from ~.15 to .678 on 9+ million volume.

https://otce.finra.org/otce/dailyList?viewType=Additions

👍️0

glenn1919 2年前

VIRX.................................https://stockcharts.com/h-sc/ui?s=VIRX&p=W&b=5&g=0&id=p86431144783

👍️0

Invest-in-America 2年前

VIRX: Up 35% in the Post-M today. (28-Mil. Float)

👍️0

TrendTrade2016 2年前

VIRX DILUTION HITTING HARD

VIRX..............................................https://stockcharts.com/h-sc/ui?s=VIRX&p=W&b=5&g=0&id=p86431144783

👍️0

Awl416 2年前

Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan

👍️0

glenn1919 2年前

VIRX......................https://stockcharts.com/h-sc/ui?s=VIRX&p=W&b=5&g=0&id=p86431144783

The Night Stalker 3年前

https://stockcharts.com/h-sc/ui?s=virx&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2

👍️0

The Night Stalker 3年前

nice

👍️0

The Night Stalker 3年前

lil dip

👍️0

The Night Stalker 3年前

soon

👍️0

The Night Stalker 3年前

https://www.barchart.com/stocks/quotes/VIRX/technical-chart?plot=BAR&volume=total&data=I:120&density=H120&pricesOn=1&asPctChange=0&logscale=0&im=120&indicators=EXPMA(9);SMA(20);BBANDS(20,2);MACD(12,26,9)&sym=VIRX&grid=1&height=500&studyheight=100

👍️0

The Night Stalker 3年前

rip

👍️0

The Night Stalker 3年前

reasy

👍️0

The Night Stalker 3年前

nice

👍️0

The Night Stalker 3年前

dip

👍️0

The Night Stalker 3年前

dip

👍️0

The Night Stalker 3年前

nice

👍️0

The Night Stalker 3年前

ready

👍️0

Triple nickle 3年前

Break 1.81 and it’s boomage imo

👍️0

Triple nickle 3年前

Could break out at 1.68 folks

👍️0

AOuvier 5年前

$VIRX- Took a starter position @ $5.01 today. Partial Order filled

Great to see some upwards strength! GLTA

👍️0

TheSilverFox121 5年前

I just bought in at 9.07 GLTA

don't sell hold on to those shares

stock will jump big today

On February 24, 2021, and in connection with the closing of the merger, Sunesis effected a 1-for-3.5 reverse stock split. All issued and outstanding shares of common stock of Sunesis were subject to the reverse stock split.

👍️0

John_Langston 5年前

What was the RS 1 for 3?

👍️0

Jconwon 5年前

Not even on anyone's radar. 16.25-18. rough 10% with almost no volume. Morning trade is good but hard to really predict these things.

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Viracta Therapeutics Inc (VIRX)

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

Viracta Therapeutics Inc (VIRX) ニュース

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Form 8-K - Current report

Viracta Therapeutics Announces Wind Down of Operations

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Form 8-K - Current report

Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma

VIRX Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Viracta Therapeutics Inc (VIRX)

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

Viracta Therapeutics Inc (VIRX) ニュース

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Form 8-K - Current report

Viracta Therapeutics Announces Wind Down of Operations

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Form 8-K - Current report

Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma

VIRX Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

ADVFNに参加する理由

プロトレーダー向けの高機能ツール

広告を削除する